The nootropic supplement market is expected to expand from US$ 2,200 million in 2023 to US$ 4,180 million by 2033. From 2023 to 2033, global nootropic supplement sales are likely to soar at 9.0% CAGR.
A nootropic supplement, or smart drug, is a compound that presents high attractiveness to consumers who prefer more lasting mental activity and focus. Nootropics are used to treat diseases such as Alzheimer's since they offer numerous benefits for brain health and cognitive aptitude.
Primarily, this supplement is sold to consumers through two formats. One is through over-the-counter, where an individual has access to a range of nootropic supplements that do not require any prescription from a doctor or a professional. Conversely, the prescribed format refers to the nootropic supplement that can be accessed only after getting approval from a doctor or health professional.
Hectic, urban lifestyles have increased cognitive, focus, and other related health concerns. To reduce these concerns, there is a growing preference for nootropic supplement added to meals and on-the-go products that are easy to consume and widely available. Due to the broad product portfolio, consumers can select a nootropic supplement to cater to a specific need.
The report reveals projections of up to 60% of global consumers planning to improve their health and wellness over the next year. This bodes well for the nootropic supplement market. It also notes that 79% of United States consumers say taking the supplement is vital to their overall health. 67% of global nutritional supplement users plan to continue using the supplement over the next year, and 49% of all supplement users say they would be willing to spend more on supplement.
| Attributes | Details |
|---|---|
| Nootropic Supplement Business Size (2023E) | US$ 2,200 million |
| Nootropic Supplement Business Projected Size (2033F) | US$ 4,180 million |
| Value CAGR (2023 to 2033) | 9.0% |
| Top 3 Countries Value Share | 30.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global nootropic supplement sales grew at a CAGR of 8.4% from 2018 to 2022. By 2033, sales of nootropic supplement are projected to progress at 9.0% CAGR. These products are easy to consume, fairly widely available, and have several health benefits, making them a popular choice among consumers globally.
The growing popularity of consumers wanting robust brain health resulted in high demand in the nootropic supplement market. Increasing expenditure on memory supplement is another key factor driving market growth. Consumers across the globe are shifting their preferences towards supplements containing natural ingredients. This is creating lucrative growth opportunities for nootropic supplement manufacturers.
Another industry-influencing trend is using convenient delivery forms to improve distribution channels. Companies are investing in advanced technologies to ensure products contain naturally sourced ingredients. The nootropic supplement business has grown steadily over the past decade. Aspects such as increasing awareness of cognitive health, a rising aging population, and a rise in mental health problems have subsidized this growth.
There has been a noteworthy increase in customer awareness and interest in nootropic supplement. Individuals are becoming more active in their cognitive health and looking for products to improve memory, emphasis, and overall brain function. Customers are screening a preference for natural and botanical ingredients over synthetic compounds. Ginkgo Biloba, Bacopa Monnieri, Ashwagandha, and Lion's Mane Mushroom have become popular due to their cognitive-enhancing properties.
Nootropic stacks, blends of diverse ingredients created to work synergistically to enhance cognitive benefits, are becoming increasingly popular. These stacks target precise cognitive functions such as improving memory, concentration, and mood stabilization. Easy access to e-commerce platforms has played a vital role in the sales development. Customers can easily research and buy products online, increasing the number of direct-to-consumer brands.
| Attributes | Key Factors |
|---|---|
| Latest Trends |
|
| Growth Hindrances |
|
| Upcoming Opportunities |
|
Principal Consultant
The United States has one of the prominently growing and leading nootropic supplement markets globally, owing to rising demand for brain health products. It is expected to reach US$ 791.8 million by 2033.
China-based businesses are still emerging players in the nootropic supplement market. However, it carries high potential as nootropic supplements in China are domestically manufactured and imported, giving consumers a wide array of choices. The market in China is expected to grow at a significant 6.8% CAGR through 2033. Research progress and widespread awareness is a key factor driving growth in the nootropic supplement market in Germany and is expected to drive growth at 3.3% CAGR in the market through 2033.
| Countries | CAGR (2023 to 2033) |
|---|---|
| United States | 7.8% |
| China | 6.8% |
| Germany | 3.3% |
The United States nootropic supplement market is poised to exhibit a CAGR of 7.8% during the assessment period. By 2033, the United States' size is expected to reach US$ 791.8 million. Nootropic supplement is categorized as dietary supplement by the FDA. They carry fewer stringent regulations than pharmaceutical drugs, as these supplements are primarily sold over the counter.
Nootropic supplement is primarily purchased online. This opens up the convenience of getting the product from various manufacturers and brands all in one place. The ease of purchase has made it simple for customers to explore their options and compare products. The consumer base in the United States includes students as it helps them with exams, professionals use it for work productivity, and older adults use it to keep sharp as they age. This has created peak interest in manufacturers' minds to develop nootropic supplements while considering all age groups.
Nootropic supplement market in China is anticipated to rise at a steady CAGR of 6.8% during the forecast period from 2023 to 2033. The Chinese government has steadily standardized the rules and regulations regarding health products and dietary supplements. These rules and regulations include product labeling requirements and sourcing regulations to improve safety and product quality.
Regarding the variety of supplements, locally manufactured and imported nootropic supplement is available in China. These varieties include herbal and natural supplements as well as synthetic additives. Manufacturers in China focus on creating unique formulations to gain a share in the global ecosystem. As studies regarding cognitive health advance, it is expected to bring forth new lucrative opportunities for key players.
The United Kingdom's nootropic supplement market is expected to reach a valuation of around US$ 175.3 million by 2033. The key factor contributing to the growth of the nootropic supplement market in the United Kingdom is its significant population, which focuses on natural and more sustainable solutions. Rising wellness and self-care trends have influenced consumers even more, boosting sales in the nootropic supplement market.
Several natural ingredients-based nootropic supplements have minimalistic side effects compared to their synthetic counterparts. This raises fewer concerns among potential consumers regarding the risk associated. Furthermore, health-related campaigns and online resources help influence consumers regarding the benefits of a natural nootropic supplement derived from plants and herbs.
Canada is one of the countries with a significant share of the elderly population globally. With this demographic shift comes increased awareness of cognitive health and greater interest in goods that support brain purpose and memory. Canada has specific guidelines regarding dietary supplement manufacture, counting nootropics. The Canadian government has recognized standards for safety, quality, and labeling.
Canada’s customers often favor natural and traditional ingredients. Products that contain herbs and botanicals that are well-known and used in conventional medicine may be especially appealing. Consumers are famous for their high standards of product superiority and safety. Businesses that want to succeed must prioritize raw material quality and experience rigorous testing.
The nootropic supplement market is expected to surge at a CAGR of 3.3% in Germany by 2033. Educational campaigns about the cognitive health and benefits of nootropic supplements can help build consumer confidence in this product category. Canada is known for its technological progress and research capabilities. Companies engaged in cutting-edge cognitive health research and developing innovative nootropic products can succeed.
Canadian consumers tend to value brands that are reputable and trustworthy. Companies with a reputation for quality and dependability may have an advantage in gaining customer trust. As e-commerce grows, several consumers still favor buying products over traditional retail channels. Creating partnerships with regional distributors or retailers can be beneficial.
Being sensitive to German culture and customs is significant for a thriving industry. This comprises considerations around packaging, messaging, and promotional activities. Constructing relationships with medical professionals and receiving their endorsements or referrals can effectively build customer credibility and trust.
| Segment | Market Value (2023) |
|---|---|
| Natural (Ingredient Type) | US$ 2,546.8 million |
| Over-the-Counter (Product category) | US$ 3,130.1 million |
| Capsules/Tablets(Form) | US$ 2,174.3 million |
Based on ingredient type, demand is expected to remain high for naturally sourced ingredients during the assessment period. With a noteworthy share of around 69.3%, the natural ingredient types segment is projected to reach a valuation of US$ 2,546.8 million in 2033.
Naturally sourced ingredients used for the formulation of nootropic supplements are preferred by consumers due to their significant neuro-enhancement and neuroprotective benefits. One of these ingredients is Gingko Biloba, which is primarily used to improve perceptual and motor functions. According to the market report, Ginseng has consistently improved in the cognitive area across sports. For instance, an individual in the education profession might go for ashwagandha as it shows better results in improving social cognition.
The over-the-counter segment is anticipated to thrive at 8.6% CAGR during the projection period to reach a valuation of US$ 3,130.1 million in 2033. The over-the-counter (OTC) supplement category products do not require a prescription. This supplement segment caters to all age groups, from minors to senior citizens, to treat minor health problems.
Furthermore, the price of any nootropic supplement sold through OTC is less expensive when compared to a prescription-based supplement. The primary factor contributing to the growth of the OTC product category is the ease of accessibility that it provides. Consumers can readily buy this supplement category at pharmacies, drug stores, and online retailers.
The capsules/tablets segment is expected to register a CAGR of 6.5% from 2023 to 2033. The target segment will likely reach US$ 2,174.3 million by the end of 2033. Factors such as the longer shelf life of capsules/tablets concerning powder or drinks form easy to store, consume, and transport contribute to the growth of the capsules/tablets format.
According to market analysis, consumers are getting pickier, with approximately 58% stating that their supplement is essential to taste good. Convenience is paramount, whether they are opting for traditional tablets and capsules or simply looking for a delivery form that's fun for them to take.
The online retailers segment is expected to register a CAGR of 8.6% from 2018 to 2022 and a CAGR of 9.1% from 2023 to 2033. The convenience and accessibility offered by online platforms have revolutionized how consumers shop, enabling them to browse and purchase products from the comfort of their homes. Nootropic supplement, known for its health benefits regarding brain health support, can now reach a wider audience through these digital channels.
By utilizing e-commerce and online retail platforms, nootropics supplement manufacturers and suppliers can access a global business, surpassing geographical limitations and reaching customers beyond traditional retail boundaries. This expansion creates opportunities for increased sales and revenue generation. Online channels offer comprehensive product information, customer reviews, and recommendations, which contribute to building consumer trust and confidence in nootropic supplements.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The ecosystem offers a wide range of products that provide individual and nootropics stacks (combinations of different nootropics) targeting brain health. Several companies have been engaged in the nootropics supplement trade. Several established players and several medium and small-sized players categorize the industry. Product launches are key growth initiatives businesses undertake to gain a competitive advantage. Product manufacturers are presenting new variations in the nootropic product category to appeal to a broader customer base.
For instance,
| Attribute | Details |
|---|---|
| Estimated Nootropic Supplement Size (2023) | US$ 2,200 million |
| Projected Nootropic Supplement Valuation (2033) | US$ 4,180 million |
| Value-based CAGR (2023 to 2033) | 9.0% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Sales Analysis | US$ million for Value, Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; and the Middle East and Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, and others. |
| Key Segments Covered | Ingredient Type, Product Category, Form, Sales Channel |
| Key Companies Profiled | Onnit Labs; Mental Mojo LLC; NooCube; Mind Lab Pro; TruBrain; Peak Nootropics; Zhou Nutrition; Kimera Koffee; Neu Drink; Accelerated Intelligence Inc; AlternaScript LLC; Cephalon Inc.; SupNootropic Bio Co. Ltd.; Teva Pharmaceutical Industries Ltd; Nootrobox Inc. |
Throughout the forecast period, the nootropic supplement business is expected to grow at a CAGR of 9.0%.
By 2033, the nootropic supplement ecosystem is expected to be worth US$ 4,180 million.
The natural ingredient type segment will likely garner a value share of 64.3% by 2023
The online retailers segment under sales channel category is predicted to grow significantly.
Some of the key players include Onnit Labs, Mental Mojo LLC, NooCube, Mind Lab Pro, TruBrain, etc.
1. Executive Summary
1.1. Global Sales Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Wheel of Fortune
1.5. Analysis and Recommendations
2. Overview
2.1. Coverage / Taxonomy
2.2. Definition of Market By Country
3. Dynamics
3.1. Drivers
3.1.1. Supply Side Drivers
3.1.2. Demand Side drivers
3.1.3. Economic Side Drivers
3.2. Restraints
3.3. Opportunity
3.4. Trends By Region
3.5. Product Launches
3.6. Product Claims & Nutritional Information Scan by Buyers
3.7. Macro-Economic Factors
3.8. Forecast Factors - Relevance & Impact
4. Regulations
4.1. Packaging & Labelling Regulations
4.2. Certifications and Certifying Agency Overview
4.3. Import/Export Policies
4.4. Formula Requirements
4.5. Standards as per institutions
4.5.1. FDA
4.5.2. USDA
4.5.3. FASSAI
4.5.4. EU Commissions
5. Global Market- Pricing Analysis
5.1. Price Point Assessment by Region
5.1.1. Manufacturer Level Pricing
5.1.2. Distributor Level Pricing
5.1.3. Retailer Level Pricing
5.2. Price Point Assessment By Form
5.3. Factors Influencing Price
6. Value Chain Analysis
6.1. Operating margins at each node of supply chain
6.2. List of Active Participants
6.2.1. Raw Material Suppliers
6.2.2. Product Manufacturers
7. Global Market Size (in Value (US$ million) and Volume (Units) Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Size in Value (US$ million) and Volume (Units) Analysis, 2018 to 2022
7.2. Current and Future Size in Value (US$ million) and Volume (Units) Analysis, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Ingredient Type
8.1. Introduction / Key Findings
8.2. Historical Size in Value (US$ million) and Volume (Units) Analysis By Ingredient Type, 2018 to 2022
8.3. Current and Future Size in Value (US$ million) and Volume (Units) Analysis and Forecast By Ingredient Type, 2023 to 2033
8.3.1. Natural
8.3.1.1. Panax Ginseng
8.3.1.2. Ginkgo Biloba
8.3.1.3. Asiatic Pennywort
8.3.1.4. Ashwagandha
8.3.1.5. Bacopa Monnieri
8.3.1.6. Guarana
8.3.1.7. Eleuthero
8.3.1.8. Rhodiola Rosea
8.3.1.9. Schisandra Chinensis
8.3.1.10. Others (Maca, etc.)
8.3.2. Synthetic
8.3.2.1. Racetams
8.3.2.2. Modafinil
8.3.2.3. Sunifiram
8.3.2.4. Phosphatidylserine
8.3.2.5. Choline
8.3.2.6. DMAE
8.3.2.7. Unifiram
8.3.2.8. Hydrafinil
8.3.2.9. Citicoline
8.3.2.10. Others (Adranfinil, etc.)
8.4. Business Attractiveness Analysis By Ingredient Type
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Category
9.1. Introduction / Key Findings
9.2. Historical Size (in Value (US$ million) and Volume (Units) Analysis By Product Category, 2018 to 2022
9.3. Current and Future Size (in Value (US$ million) and Volume (Units) Analysis and Forecast By Product Category, 2023 to 2033
9.3.1. Prescribed
9.3.2. Over-the-Counter
9.4. Business Attractiveness Analysis By Product Category
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form
10.1. Introduction / Key Findings
10.2. Historical Size (in Value (US$ million) and Volume (Units) Analysis By Form, 2018 to 2022
10.3. Current and Future Size (in Value (US$ million) and Volume (Units) Analysis and Forecast By Form, 2023 to 2033
10.3.1. Capsules/Tablets
10.3.2. Powder
10.3.3. Drinks
10.3.4. Gummy
10.4. Business Attractiveness Analysis By Form
11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Size in Value (US$ million) and Volume (Units) Analysis By Distribution Channel, 2018 to 2022
11.3. Current and Future Size in Value (US$ million) and Volume (Units) Analysis and Forecast By Distribution Channel, 2023 to 2033
11.3.1. Health Food Stores
11.3.2. Pharmacies and Drugstores
11.3.3. Professional Healthcare Practitioners
11.3.4. Nutrition Stores
11.3.5. Healthcare Professionals
11.3.6. Online Retailers
11.4. Business Attractiveness Analysis By Distribution Channel
12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
12.1. Introduction
12.2. Historical Size in Value (US$ million) and Volume (Units) Analysis By Region, 2018 to 2022
12.3. Current Size in Value (US$ million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East & Africa
12.4. Business Attractiveness Analysis By Region
13. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022
13.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. United States
13.2.1.2. Canada
13.2.2. By Ingredient Type
13.2.3. By Product Category
13.2.4. By Form
13.2.5. By Distribution Channel
13.3. Business Attractiveness Analysis
13.3.1. By Country
13.3.2. By Ingredient Type
13.3.3. By Product Category
13.3.4. By Form
13.3.5. By Distribution Channel
13.4. Trends
13.5. Key Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022
14.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Brazil
14.2.1.2. Mexico
14.2.1.3. Colombia
14.2.1.4. Argentina
14.2.1.5. Rest of Latin America
14.2.2. By Ingredient Type
14.2.3. By Product Category
14.2.4. By Form
14.2.5. By Distribution Channel
14.3. Business Attractiveness Analysis
14.3.1. By Country
14.3.2. By Ingredient Type
14.3.3. By Product Category
14.3.4. By Form
14.3.5. By Distribution Channel
14.4. Trends
14.5. Key Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy,
15.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. Germany
15.2.1.2. United Kingdom
15.2.1.3. France
15.2.1.4. Italy
15.2.1.5. Spain
15.2.1.6. BENELUX
15.2.1.7. Nordic
15.2.1.8. Russia
15.2.1.9. Poland
15.2.1.10. Rest of Europe
15.2.2. By Ingredient Type
15.2.3. By Product Category
15.2.4. By Form
15.2.5. By Distribution Channel
15.3. Business Attractiveness Analysis
15.3.1. By Country
15.3.2. By Ingredient Type
15.3.3. By Product Category
15.3.4. By Form
15.3.5. By Distribution Channel
15.4. Trends
15.5. Key Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022
16.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. China
16.2.1.2. Japan
16.2.1.3. South Korea
16.2.2. By Ingredient Type
16.2.3. By Product Category
16.2.4. By Form
16.2.5. By Distribution Channel
16.3. Business Attractiveness Analysis
16.3.1. By Country
16.3.2. By Ingredient Type
16.3.3. By Product Category
16.3.4. By Form
16.3.5. By Distribution Channel
16.4. Trends
16.5. Key Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
17.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022
17.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033
17.2.1. By Country
17.2.1.1. India
17.2.1.2. Thailand
17.2.1.3. Malaysia
17.2.1.4. Indonesia
17.2.1.5. Singapore
17.2.1.6. Rest of South Asia
17.2.2. By Ingredient Type
17.2.3. By Product Category
17.2.4. By Form
17.2.5. By Distribution Channel
17.3. Business Attractiveness Analysis
17.3.1. By Country
17.3.2. By Ingredient Type
17.3.3. By Product Category
17.3.4. By Form
17.3.5. By Distribution Channel
17.4. Trends
17.5. Key Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
18.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022
18.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033
18.2.1. By Country
18.2.1.1. Australia
18.2.1.2. New Zealand
18.2.2. By Ingredient Type
18.2.3. By Product Category
18.2.4. By Form
18.2.5. By Distribution Channel
18.3. Business Attractiveness Analysis
18.3.1. By Country
18.3.2. By Ingredient Type
18.3.3. By Product Category
18.3.4. By Form
18.3.5. By Distribution Channel
18.4. Trends
18.5. Key Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
19.1. Historical Size (US$ million) and Volume Trend Analysis By Taxonomy, 2018 to 2022
19.2. Forecast Size (US$ million) and Volume Forecast By Taxonomy, 2023 to 2033
19.2.1. By Country
19.2.1.1. UAE
19.2.1.2. Saudi Arabia
19.2.1.3. Other GCC Countries
19.2.1.4. North Africa
19.2.1.5. South Africa
19.2.1.6. Central Africa
19.2.2. By Ingredient Type
19.2.3. By Product Category
19.2.4. By Form
19.2.5. By Distribution Channel
19.3. Business Attractiveness Analysis
19.3.1. By Country
19.3.2. By Ingredient Type
19.3.3. By Product Category
19.3.4. By Form
19.3.5. By Distribution Channel
19.4. Trends
19.5. Key Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Country-level Market Analysis, 2023
20.1. United States Market Analysis
20.1.1. By Ingredient Type
20.1.2. By Product Category
20.1.3. By Form
20.1.4. By Distribution Channel
20.2. Canada Market Analysis
20.2.1. By Ingredient Type
20.2.2. By Product Category
20.2.3. By Form
20.2.4. By Distribution Channel
20.3. Brazil Market Analysis
20.3.1. By Ingredient Type
20.3.2. By Product Category
20.3.3. By Form
20.3.4. By Distribution Channel
20.4. Mexico Market Analysis
20.4.1. By Ingredient Type
20.4.2. By Product Category
20.4.3. By Form
20.4.4. By Distribution Channel
20.5. Colombia Market Analysis
20.5.1. By Ingredient Type
20.5.2. By Product Category
20.5.3. By Form
20.5.4. By Distribution Channel
20.6. Argentina Market Analysis
20.6.1. By Ingredient Type
20.6.2. By Product Category
20.6.3. By Form
20.6.4. By Distribution Channel
20.7. Germany Market Analysis
20.7.1. By Ingredient Type
20.7.2. By Product Category
20.7.3. By Form
20.7.4. By Distribution Channel
20.8. United States Market Analysis
20.8.1. By Ingredient Type
20.8.2. By Product Category
20.8.3. By Form
20.8.4. By Distribution Channel
20.9. France Market Analysis
20.9.1. By Ingredient Type
20.9.2. By Product Category
20.9.3. By Form
20.9.4. By Distribution Channel
20.10. Italy Market Analysis
20.10.1. By Ingredient Type
20.10.2. By Product Category
20.10.3. By Form
20.10.4. By Price Range
20.10.5. By Distribution Channel
20.11. Spain Market Analysis
20.11.1. By Ingredient Type
20.11.2. By Product Category
20.11.3. By Form
20.11.4. By Distribution Channel
20.12. Belgium Market Analysis
20.12.1. By Ingredient Type
20.12.2. By Product Category
20.12.3. By Form
20.12.4. By Distribution Channel
20.13. Netherlands Market Analysis
20.13.1. By Ingredient Type
20.13.2. By Product Category
20.13.3. By Form
20.13.4. By Distribution Channel
20.14. Nordic Market Analysis
20.14.1. By Ingredient Type
20.14.2. By Product Category
20.14.3. By Form
20.14.4. By Distribution Channel
20.15. Russia Market Analysis
20.15.1. By Ingredient Type
20.15.2. By Product Category
20.15.3. By Form
20.15.4. By Distribution Channel
20.16. Poland Market Analysis
20.16.1. By Ingredient Type
20.16.2. By Product Category
20.16.3. By Form
20.16.4. By Distribution Channel
20.17. Ukraine Market Analysis
20.17.1. By Ingredient Type
20.17.2. By Product Category
20.17.3. By Form
20.17.4. By Distribution Channel
20.18. China Market Analysis
20.18.1. By Ingredient Type
20.18.2. By Product Category
20.18.3. By Form
20.18.4. By Distribution Channel
20.19. Japan Market Analysis
20.19.1. By Ingredient Type
20.19.2. By Product Category
20.19.3. By Form
20.19.4. By Distribution Channel
20.20. S Korea Market Analysis
20.20.1. By Ingredient Type
20.20.2. By Product Category
20.20.3. By Form
20.20.4. By Distribution Channel
20.21. India Market Analysis
20.21.1. By Ingredient Type
20.21.2. By Product Category
20.21.3. By Form
20.21.4. By Distribution Channel
20.22. Thailand Market Analysis
20.22.1. By Ingredient Type
20.22.2. By Product Category
20.22.3. By Form
20.22.4. By Distribution Channel
20.23. Malaysia Market Analysis
20.23.1. By Ingredient Type
20.23.2. By Product Category
20.23.3. By Form
20.23.4. By Distribution Channel
20.24. Indonesia Market Analysis
20.24.1. By Ingredient Type
20.24.2. By Product Category
20.24.3. By Form
20.24.4. By Distribution Channel
20.25. Singapore Market Analysis
20.25.1. By Ingredient Type
20.25.2. By Product Category
20.25.3. By Form
20.25.4. By Distribution Channel
20.26. Australia Market Analysis
20.26.1. By Ingredient Type
20.26.2. By Product Category
20.26.3. By Form
20.26.4. By Distribution Channel
20.27. New Zealand Market Analysis
20.27.1. By Ingredient Type
20.27.2. By Product Category
20.27.3. By Form
20.27.4. By Distribution Channel
20.28. UAE Market Analysis
20.28.1. By Ingredient Type
20.28.2. By Product Category
20.28.3. By Form
20.28.4. By Distribution Channel
20.29. Saudi Arabia Market Analysis
20.29.1. By Ingredient Type
20.29.2. By Product Category
20.29.3. By Form
20.29.4. By Distribution Channel
20.30. North Africa Market Analysis
20.30.1. By Ingredient Type
20.30.2. By Product Category
20.30.3. By Form
20.30.4. By Distribution Channel
20.31. South Africa Market Analysis
20.31.1. By Ingredient Type
20.31.2. By Product Category
20.31.3. By Form
20.31.4. By Distribution Channel
20.32. Central Africa Market Analysis
20.32.1. By Ingredient Type
20.32.2. By Product Category
20.32.3. By Form
20.32.4. By Distribution Channel
21. Structure Analysis
21.1. Global Market Competition - a Dashboard View
21.2. Industry Structure Analysis
21.2.1. % tier 1 players
21.2.2. % tier 2 players
21.2.3. % tier 3 players
21.3. Global Market Company Share Analysis
21.3.1. For Tier 1 Players, 2022
21.3.2. Company Share Analysis of Top 5 Players, By Region
22. Competition Analysis
22.1. Competition Deep Dive
22.1.1. Onnit Labs
22.1.1.1. Product Portfolio
22.1.1.2. Product Claim
22.1.1.3. Revenue by Segments (Product/Channel/Region)
22.1.1.4. Sales Footprint
22.1.1.5. Strategy Overview
22.1.1.5.1. Marketing Strategy
22.1.1.5.2. Product Strategy
22.1.1.5.3. Channel Strategy
22.1.1.6. SWOT Analysis
22.1.2. Mental Mojo LLC
22.1.2.1. Product Portfolio
22.1.2.2. Product Claim
22.1.2.3. Revenue by Segments (Product/Channel/Region)
22.1.2.4. Sales Footprint
22.1.2.5. Strategy Overview
22.1.2.5.1. Marketing Strategy
22.1.2.5.2. Product Strategy
22.1.2.5.3. Channel Strategy
22.1.2.6. SWOT Analysis
22.1.3. NooCube
22.1.3.1. Product Portfolio
22.1.3.2. Product Claim
22.1.3.3. Revenue by Segments (Product/Channel/Region)
22.1.3.4. Sales Footprint
22.1.3.5. Strategy Overview
22.1.3.5.1. Marketing Strategy
22.1.3.5.2. Product Strategy
22.1.3.5.3. Channel Strategy
22.1.3.6. SWOT Analysis
22.1.4. Mind Lab Pro
22.1.4.1. Product Portfolio
22.1.4.2. Product Claim
22.1.4.3. Revenue by Segments (Product/Channel/Region)
22.1.4.4. Sales Footprint
22.1.4.5. Strategy Overview
22.1.4.5.1. Marketing Strategy
22.1.4.5.2. Product Strategy
22.1.4.5.3. Channel Strategy
22.1.4.6. SWOT Analysis
22.1.5. TruBrain
22.1.5.1. Product Portfolio
22.1.5.2. Product Claim
22.1.5.3. Revenue by Segments (Product/Channel/Region)
22.1.5.4. Sales Footprint
22.1.5.5. Strategy Overview
22.1.5.5.1. Marketing Strategy
22.1.5.5.2. Product Strategy
22.1.5.5.3. Channel Strategy
22.1.5.6. SWOT Analysis
22.1.6. Peak Nootropics
22.1.6.1. Product Portfolio
22.1.6.2. Product Claim
22.1.6.3. Revenue by Segments (Product/Channel/Region)
22.1.6.4. Sales Footprint
22.1.6.5. Strategy Overview
22.1.6.5.1. Marketing Strategy
22.1.6.5.2. Product Strategy
22.1.6.5.3. Channel Strategy
22.1.6.6. SWOT Analysis
22.1.7. Zhou Nutrition
22.1.7.1. Product Portfolio
22.1.7.2. Product Claim
22.1.7.3. Revenue by Segments (Product/Channel/Region)
22.1.7.4. Sales Footprint
22.1.7.5. Strategy Overview
22.1.7.5.1. Marketing Strategy
22.1.7.5.2. Product Strategy
22.1.7.5.3. Channel Strategy
22.1.7.6. SWOT Analysis
22.1.8. Kimera Koffee
22.1.8.1. Product Portfolio
22.1.8.2. Product Claim
22.1.8.3. Revenue by Segments (Product/Channel/Region)
22.1.8.4. Sales Footprint
22.1.8.5. Strategy Overview
22.1.8.5.1. Marketing Strategy
22.1.8.5.2. Product Strategy
22.1.8.5.3. Channel Strategy
22.1.8.6. SWOT Analysis
22.1.9. Neu Drink
22.1.9.1. Product Portfolio
22.1.9.2. Product Claim
22.1.9.3. Revenue by Segments (Product/Channel/Region)
22.1.9.4. Sales Footprint
22.1.9.5. Strategy Overview
22.1.9.5.1. Marketing Strategy
22.1.9.5.2. Product Strategy
22.1.9.5.3. Channel Strategy
22.1.9.6. SWOT Analysis
22.1.10. Accelerated Intelligence Inc.
22.1.10.1. Product Portfolio
22.1.10.2. Product Claim
22.1.10.3. Revenue by Segments (Product/Channel/Region)
22.1.10.4. Sales Footprint
22.1.10.5. Strategy Overview
22.1.10.5.1. Marketing Strategy
22.1.10.5.2. Product Strategy
22.1.10.5.3. Channel Strategy
22.1.10.6. SWOT Analysis
22.1.11. AlternaScript LLC
22.1.11.1. Product Portfolio
22.1.11.2. Product Claim
22.1.11.3. Revenue by Segments (Product/Channel/Region)
22.1.11.4. Sales Footprint
22.1.11.5. Strategy Overview
22.1.11.5.1. Marketing Strategy
22.1.11.5.2. Product Strategy
22.1.11.5.3. Channel Strategy
22.1.11.6. SWOT Analysis
22.1.12. Cephalon Inc.
22.1.12.1. Product Portfolio
22.1.12.2. Product Claim
22.1.12.3. Revenue by Segments (Product/Channel/Region)
22.1.12.4. Sales Footprint
22.1.12.5. Strategy Overview
22.1.12.5.1. Marketing Strategy
22.1.12.5.2. Product Strategy
22.1.12.5.3. Channel Strategy
22.1.12.6. SWOT Analysis
22.1.13. SupNootropic bio co. ltd.
22.1.13.1. Product Portfolio
22.1.13.2. Product Claim
22.1.13.3. Revenue by Segments (Product/Channel/Region)
22.1.13.4. Sales Footprint
22.1.13.5. Strategy Overview
22.1.13.5.1. Marketing Strategy
22.1.13.5.2. Product Strategy
22.1.13.5.3. Channel Strategy
22.1.13.6. SWOT Analysis
22.1.14. Teva Pharmaceutical Industries Ltd
22.1.14.1. Product Portfolio
22.1.14.2. Product Claim
22.1.14.3. Revenue by Segments (Product/Channel/Region)
22.1.14.4. Sales Footprint
22.1.14.5. Strategy Overview
22.1.14.5.1. Marketing Strategy
22.1.14.5.2. Product Strategy
22.1.14.5.3. Channel Strategy
22.1.14.6. SWOT Analysis
22.1.15. Nootrobox Inc.
22.1.15.1. Product Portfolio
22.1.15.2. Product Claim
22.1.15.3. Revenue by Segments (Product/Channel/Region)
22.1.15.4. Sales Footprint
22.1.15.5. Strategy Overview
22.1.15.5.1. Marketing Strategy
22.1.15.5.2. Product Strategy
22.1.15.5.3. Channel Strategy
22.1.15.6. SWOT Analysis
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Food and Beverage Insights
View Reports
Nootropic Supplement Market
